Ignite Creation Date:
2025-12-24 @ 11:48 AM
Ignite Modification Date:
2025-12-28 @ 9:29 AM
Study NCT ID:
NCT06304961
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2024-03-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Investigate Relative Bioavailability of Two Different Dosage Forms for Tozorakimab Via Subcutaneous Administration in Healthy Volunteers
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-08
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-09
Completion Date Type:
ACTUAL
First Submit Date:
2024-03-05
First Submit QC Date:
None
Study First Post Date:
2024-03-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-16
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL